Active	Status	Sponsor type	Region	Phase	Filter
3 Active 1 Inactive 4 All	Not yet recruiting Recruiting Enrolling by invitation Active, not recruiting Available No longer recruiting	Industry lead sponsor Industry collaborator Coop Other	US Canada Japan Europe RoW	N/A 1 2 3 4	Highlight changes:- Show only changed items Enrollment:

Advanced Filters

3 Trials

Active Trials   

 

Export

Trial + Data / Events	Status	Ph	N	Region	Interventions	Sponsor	Conditions	Primary compl	Study compl
Swain, Mark
NAVIGATE, NCT04365868 / 2019-001983-31: Study Evaluating the Efficacy and Safety of Belapectin for the Prevention of Esophageal Varices in NASH Cirrhosis	Active, not recruiting	2b	357	Europe, Canada, US, RoW	belapectin, GR-MD-02, galactoarabino rhamnogalacturonate, Placebo	Galectin Therapeutics Inc., Galectin Therapeutics Inc	Prevention of Esophageal Varices, NASH - Nonalcoholic Steatohepatitis, Cirrhosis	12/24	12/24
NCT04733456: Brain Activity and Oxygenation Inflammatory Bowel Disease (IBD) Patients	Recruiting	N/A	40	Canada	Quality of life questionnaires, NIRS, Stool Collection, Blood and urine collection	University of Calgary	IBD, Maladaptive Behavior Associated With Physical Illness	01/25	01/26
CaNAL, NCT03569826: Canadian Network for Autoimmune Liver Disease	Recruiting	N/A	2500	Canada	Observational; no intervention	University Health Network, Toronto	Primary Bilary Cirrhosis (PBC), Autoimmune Hepatitis, Overlap Syndrome	12/28	12/28
Mawani, Shefina
No trials found